Enhancement of the cell therapeutic potency using low-molecular weight heparin protamine complex
Project/Area Number |
26861052
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
General surgery
|
Research Institution | Dokkyo Medical University |
Principal Investigator |
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2016: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2015: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2014: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 再生医療 / 細胞移植 / 脂肪由来間質細胞 / 細胞キャリア / 下部尿路障害 / 腹圧性尿失禁 / サイトカイン |
Outline of Final Research Achievements |
Fragmin/Protamine Nano-Particles (F/P NPs) are recently developed as low-molecular weight, biodegradable carriers for adipose-derived stromal cells (ASCs). We examined the ability of ASCs/F/P NPs aggregates to rescue limb loss in a mouse model of hindlimb ischemia and increase in urethral resistance in a rat model of vaginal distention. The F/P NPs augmented the effects of ASCs on angiogenesis and reversal of limb ischemia on postoperative days 7 and 14. Leak point pressure (LPP) decreased after vaginal distension (VD) and was recovered after the periurethral injection of ASCs and ASCs/F/P NPs aggregates of 7 and 14 days after VD treatment.
|
Report
(4 results)
Research Products
(6 results)
-
[Journal Article] Low-molecular weight heparin protamine complex augmented the potential of adipose-derived stromal cells to ameliorate limb ischemia2016
Author(s)
Satoko Kishimoto, Ken-ichi Inoue, Shingo Nakamura, Hidemi Hattori, Masayuki Ishihara, Masashi Sakuma, Shigeru Toyoda, Hideki Iwaguro, Isao Taguchi, Teruo Inoue, Ken-ichiro Yoshida
-
Journal Title
Atherosclerosis
Volume: 249
Pages: 132-139
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-